<?xml version="1.0" encoding="UTF-8"?>
<p>Critical patients show an unhealthy immune response that eventually causes hyper-inflammation. This exaggerated immune response should be controlled and checked by different approaches and procedures. As discussed earlier, inflammatory cytokines are released at the site of infection and cause infiltration of lungs. Clinical trials are underway to identify the benefits of blocking cytokine storm targeting IL-1Î² and IL-6, as shown in 
 <xref rid="ijerph-17-05904-t003" ref-type="table">Table 3</xref>.
</p>
